Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
Latest & greatest articles for dvt
The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on dvt or other clinical topics then use Trip today.
This page lists the very latest high quality evidence on dvt and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.
What is Trip?
Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.
Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.
As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.
For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via email@example.com
Treatment of distal deepveinthrombosis. The treatment of distal (below the knee) deepveinthrombosis (DVT) is not clearly established. Distal DVT can either be treated with anticoagulation, or monitored with close follow-up to detect progression to the proximal veins (above the knee), which requires anticoagulation. Proponents of this monitoring strategy base their decision to withhold anticoagulation on the fact that progression is rare and most people can be spared from potential bleeding (...) and other adverse effects of anticoagulation.To assess the effects of different treatment interventions for people with distal (below the knee) deepveinthrombosis (DVT).The Cochrane Vascular Information Specialist searched the Cochrane Vascular Specialised Register, CENTRAL, MEDLINE, Embase and CINAHL databases and World Health Organization International Clinical Trials Registry Platform and ClinicalTrials.gov trials registers to 12 February 2019. We also undertook reference checking to identify
DVT prevention for travellers DVT prevention for travellers | Topics A to Z | CKS | NICE Search CKS… Menu DVT prevention for travellers DVT prevention for travellers Last revised in August 2018 Deepveinthrombosis (DVT) can occur as a result of long distance travel. The risk of travel-related DVT in healthy people is extremely low Management Background information DVT prevention for travellers: Summary Deepveinthrombosis (DVT) is the formation of a thrombus (blood clot) in a deepvein, which (...) . Inherited blood-clotting abnormalities. Large varicose veins, or chronic venous insufficiency. Limited mobility (for example, a lower-limb fracture in plaster). Obesity. Polycythaemia. Pregnancy, or up to six weeks postpartum. Previous DVT or PE. Recent surgery or trauma, particularly to the abdomen, pelvic region, or legs. Thrombophilia, or other thrombotic states (for example, heart failure, recent myocardial infarction, severe infection, inflammatory bowel disease). Use of oestrogens, such as oral
Point of Care Ultrasound for Assessment of Patients with DeepVeinThrombosis in Emergency Departments: Clinical Utility and Cost-Effectiveness Point of Care Ultrasound for Assessment of Patients with DeepVeinThrombosis in Emergency Departments: Clinical Utility and Cost-Effectiveness | CADTH.ca Find the information you need Point of Care Ultrasound for Assessment of Patients with DeepVeinThrombosis in Emergency Departments: Clinical Utility and Cost-Effectiveness Point of Care Ultrasound (...) for Assessment of Patients with DeepVeinThrombosis in Emergency Departments: Clinical Utility and Cost-Effectiveness Last updated: August 29, 2019 Project Number: RB1381-000 Product Line: Research Type: Devices and Systems Report Type: Summary of Abstracts Result type: Report Question What is the clinical utility of point of care ultrasound for the assessment of patients with deepveinthrombosis in the emergency department? What is the cost effectiveness of point of care ultrasound for the assessment
Bilateral upper extremity deepveinthromboses: not an effortless diagnosis Bilateral Upper Extremity DeepVeinThromboses: Not an Effortless Diagnosis – Clinical Correlations Search Bilateral Upper Extremity DeepVeinThromboses: Not an Effortless Diagnosis September 25, 2019 5 min read By Alvaro Vargas, MD Peer Reviewed Learning Objectives Understand the classification and common causes of Upper Extremity DeepVeinThromboses (upper extremity DVTs or UEDVTs) Explain the pathophysiology behind (...) , Bernardi E, et al. Upper-extremity deepveinthrombosis. Risk factors, diagnosis, and complications. Arch Intern Med. 1997;157(1):57-62. Tilney ML, Griffiths HJ, Edwards EA. Natural history of major venousthrombosis of the upper extremity. Arch Surg. 1970;101(6):792-6. Illig KA, Doyle AJ. A comprehensive review of Paget-Schroetter syndrome. J Vasc Surg. 2010;51(6):1538-47. Paget J. Clinical Lectures and Essays. London, UK: Longmans, Green, and Co; 1875. von Schroetter L. Erkrankungen der Gefasse
evidence of thrombus, as in the lower extremity, include loss of compression of imaged vein walls when pressure is applied on the skin during real-time imaging, and visualization of echogenic material in the vein. Indirect evidence of thrombus includes altered blood-flow patterns [11,33,34,36-38]. Loss of compressibility is consistent with acute DVT but can also occur in the presence of chronic venousthrombosis [11,34]. US is most useful in evaluation of veins peripheral to the subclavian (...) (12):1605-1611. 2. Kucher N. Clinical practice. Deep-veinthrombosis of the upper extremities. N Engl J Med. 2011;364(9):861- 869. 3. Abdullah BJ, Mohammad N, Sangkar JV, et al. Incidence of upper limb venousthrombosis associated with peripherally inserted central catheters (PICC). Br J Radiol. 2005;78(931):596-600. 4. Knudson GJ, Wiedmeyer DA, Erickson SJ, et al. Color Doppler sonographic imaging in the assessment of upper-extremity deepvenousthrombosis. AJR Am J Roentgenol. 1990;154(2):399
thrombosis (DVT) is highly debated. The only available placebo-controlled trial suggested the absence of clear benefit of anticoagulation. Many physicians feel that, beyond preventing thromboembolic complications, anticoagulation with low-molecular-weight heparin (LMWH) has the potential to improve pain control. Objectives To analyze whether LMWHs decrease pain in patients with distal deepveinthrombosis. Patients and methods Two-hundred and fifty-two patients included in a multicenter, placebo (...) Effect of anticoagulant treatment on pain in distal deepveinthrombosis: an ancillary analysis from the cactus trial Essentials Management of patients with calf deepveinthrombosis remains controversial. We conducted a post-hoc analysis of a placebo controlled LMWH randomized clinical trial. Pain was assessed using visual analogue scale at inclusion, one and six weeks. There was no difference in pain control between the two arms. SUMMARY: Background The optimal management of distal deepvein
Asymptomatic DeepVeinThrombosis is Associated with an Increased Risk of Death: Insights from the APEX Trial Asymptomatic deepveinthrombosis (DVT) diagnosed with compression ultrasound (CUS) is a common endpoint in trials assessing the efficacy of anticoagulants to prevent venous thromboembolism (VTE), but the relationship of asymptomatic thrombus to mortality remains uncertain. In the APEX trial (ClinicalTrials.gov: NCT01583218), 7,513 acutely ill hospitalized medical patients were (...) randomly assigned to extended-duration betrixaban (35-42 days) or enoxaparin (10 ± 4 days). Asymptomatic DVT was assessed once with CUS between day 32 and 47, and mortality was assessed through 77 days. A total of 309 asymptomatic DVTs were detected through CUS. Of these, 133 (4.27%) subjects were in the betrixaban group, and 176 (5.55%) subjects were in the enoxaparin group (relative risk = 0.77, 95% confidence interval [CI] = 0.62-0.97, p = 0.025, number needed to treat = 79). With respect to all
DeepveinthrombosisDeepveinthrombosis | Topics A to Z | CKS | NICE Search CKS… Menu DeepveinthrombosisDeepveinthrombosis Last revised in March 2020 Deepveinthrombosis (DVT) is the formation of a thrombus in a deepvein, usually in the legs, which partially or completely obstructs blood flow Diagnosis Management Prescribing information Background information Deepveinthrombosis: Summary Deepveinthrombosis (DVT) is the formation of a thrombus (blood clot) in a deepvein, usually (...) trauma or direct trauma to a vein (for example, intravenous catheter). Hormone treatment (for example hormone replacement therapy). Pregnancy and the postpartum period. Dehydration. The most serious complication is pulmonary embolism. The possibility of DVT should be considered if typical symptoms and signs are present, especially if the person has risk factors. Typical signs and symptoms are: Localised pain and swelling in one leg (occasionally both legs). Tenderness, skin changes including oedema
weight heparin, fondaparinux, rivaroxaban, apixaban, edoxaban, dabigatran, and/or warfarin. Generally, oral anticoagulation is continued for 3 to 6 months. In selected patients with significant thromboembolic risks, careful consideration should be given to maintaining oral anticoagulation indefinitely as long as the risks of bleeding are lower than the risks of recurrent venousthrombosis. Definition Deepveinthrombosis (DVT) is the development of a blood clot in a major deepvein in the leg, thigh (...) DeepveinthrombosisDeepveinthrombosis - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search Deepveinthrombosis Last reviewed: February 2019 Last updated: November 2018 Summary Patients who develop deepveinthrombosis (DVT) commonly have thromboembolic risk factors, such as cancer, trauma, major surgery, hospitalisation, immobilisation, pregnancy, or oral contraceptive use. However, many patients have no history
deaths annually in the United States. [ ] See the image below. CT 2014 3. Deepveinthrombosis ( DVT ) 2017 4. Aspirin as DVT prophylaxis for high risk long-haul travellers Aspirin as DVT prophylaxis for high risk long-haul travellers » Morsels of Evidence Search Evidence based medicine for general practitioners « » Feb 19 Aspirin as DVT prophylaxis for high risk long-haul travellers Categories: , by Journal reference: Cesarone MR, Belcaro G, Nicolaides AN, et al. Venousthrombosis from air travel (...) venousthrombosis ( DVT ) is clotting of blood in a deepvein of an extremity (usually calf or thigh) or the pelvis. DVT is the primary cause of pulmonary embolism. DVT results from conditions that impair venous return, lead to endothelial injury or dysfunction, or cause hypercoagulability. DVT may be asymptomatic or cause pain and swelling in an extremity; pulmonary embolism is an immediate 2013 14. Systematic review: A low Wells score and a negative D-dimer was not safe in patients with cancer
Derivation and Validation of a Prediction Model for Risk Stratification of Post-Thrombotic Syndrome in Elderly Patients with a First DeepVeinThrombosis Not all patients carry the same risk of developing a post-thrombotic syndrome (PTS), we therefore aimed to derive a prediction rule for risk stratification of PTS in patients with deepveinthrombosis (DVT). Our derivation sample included 276 patients with a first acute symptomatic lower limb DVT enrolled in a prospective cohort. We derived (...) our prediction rule using regression analysis, with the occurrence of PTS within 24 months of a DVT based on the Villalta score as outcome, and 11 candidate variables as predictors. We used bootstrapping methods for internal validation. Overall, 161 patients (58.3%) developed a PTS within 24 months of a DVT. Our prediction rule was based on five predictors (age ≥ 75 years, prior varicose vein surgery, multi-level thrombosis, concomitant antiplatelet/non-steroidal anti-inflammatory drug therapy
The case for catheter-directed thrombolysis in selected patients with acute proximal deepveinthrombosis 30042146 2019 03 18 2473-9537 2 14 2018 07 24 Blood advances Blood Adv The case for catheter-directed thrombolysis in selected patients with acute proximal deepveinthrombosis. 1799-1802 10.1182/bloodadvances.2018018622 Chiasakul Thita T 0000-0002-0443-1751 Division of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital (...) J Thromb Haemost. 2009 May;7(5):879-83 19175497 Cochrane Database Syst Rev. 2016 Nov 10;11:CD002783 27830895 J Thromb Haemost. 2005 Feb;3(2):401-2 15670059 Vasc Endovascular Surg. 2011 Jan;45(1):5-14 21193462 Ann Intern Med. 2008 Nov 18;149(10):698-707 19017588 J Vasc Surg Venous Lymphat Disord. 2014 Apr;2(2):123-30 26993176 J Thromb Haemost. 2008 Jul;6(7):1105-12 18466316
The case against catheter-directed thrombolysis in patients with proximal deepveinthrombosis 30042147 2019 03 19 2019 03 19 2473-9537 2 14 2018 07 24 Blood advances Blood Adv The case against catheter-directed thrombolysis in patients with proximal deepveinthrombosis. 1803-1805 10.1182/bloodadvances.2018018630 Poston Jacqueline N JN 0000-0003-2431-5106 Division of Hematology, Department of Medicine, University of Washington, Seattle, WA. Garcia David A DA Division of Hematology, Department (...) of Medicine, University of Washington, Seattle, WA. eng T32 HL007093 HL NHLBI NIH HHS United States Journal Article Research Support, N.I.H., Extramural Comment United States Blood Adv 101698425 2473-9529 IM Blood Adv. 2018 Jul 24;2(14):1799-1802 30042146 Humans Thrombolytic Therapy VenousThrombosis 2018 05 31 2018 06 06 2018 7 26 6 0 2018 7 26 6 0 2019 3 20 6 0 ppublish 30042147 bloodadvances.2018018630 10.1182/bloodadvances.2018018630 PMC6058231 JAMA Intern Med. 2014 Sep;174(9):1494-501 25047081 Lancet
Deepveinthrombosis Evidence Maps - Trip Database or use your Google+ account Find evidence fast ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4
Suspected Lower Extremity DeepVeinThrombosis Revised 2018 ACR Appropriateness Criteria ® 1 Suspected Lower Extremity DVT American College of Radiology ACR Appropriateness Criteria ® Suspected Lower Extremity DeepVeinThrombosis Variant 1: Suspected lower extremity deepveinthrombosis. Initial imaging. Procedure Appropriateness Category Relative Radiation Level US duplex Doppler lower extremity Usually Appropriate O CT venography lower extremity and pelvis with IV contrast May Be Appropriate (...) ??? MR venography lower extremity and pelvis without and with IV contrast May Be Appropriate O MR venography lower extremity and pelvis without IV contrast May Be Appropriate O Catheter venography pelvis and lower extremity Usually Not Appropriate ??? ACR Appropriateness Criteria ® 2 Suspected Lower Extremity DVT SUSPECTED LOWER EXTREMITY DEEPVEINTHROMBOSIS Expert Panel on Vascular Imaging: Michael Hanley, MD a ; Michael L. Steigner, MD b ; Osmanuddin Ahmed, MD c ; Ezana M. Azene, MD, PhD d
Assessment of coexisting deepveinthrombosis for risk stratification of acute pulmonary embolism In patients with acute pulmonary embolism (PE), studies have shown an association between coexisting deepveinthrombosis (DVT) and short-term prognosis. It is not known whether complete compression ultrasound testing (CCUS) improves the risk stratification of their disease beyond the recommended prognostic models.We included patients with normotensive acute symptomatic PE and prognosticated them (...) with the European Society of Cardiology (ESC) risk model for PE. Subsequently, we determined the prognostic significance of coexisting DVT in patients with various ESC risk categories. The primary endpoint was a complicated course after the diagnosis of PE, defined as death from any cause, haemodynamic collapse, or adjudicated recurrent PE.According to the ESC model, 37% of patients were low-risk, 56% were intermediate-low risk, and 6.7% were intermediate-high risk. CCUS demonstrated coexisting DVT in 375 (44